MARSEILLE, France, April 09, 2024--(BUSINESS WIRE)--Regulatory News ... that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below.

MONTPELLIER, France, April 10, 2024--(BUSINESS WIRE)--Regulatory News ... today announces its participation in the Van Lanschot Kempen's Life Sciences Conference, taking place on April 16 and ...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion ... loss disorders, today announces its participation in the Van Lanschot Kempen's Life Sciences Conference, taking place on ...

MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma ... that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below.

Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through ...

when the company is expected to show off its latest AI advancements. The conference, which is widely anticipated each year as a major showcase for Apple software news, will run Monday, June 10 ...

today announces its participation in the Van Lanschot Kempen's Life Sciences Conference, taking place on April 16 and 17, 2024, in Amsterdam, Netherlands. Sensorion’s management team will ...

Mr. Roberge, President and CEO, will make a presentation on April 17 at 4:00 p.m. EST, and will be available for one-on-one meetings throughout the conference. To register for the 2024 Bloom ...

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 ... the field of hearing loss disorders, today announces its participation in the Van Lanschot Kempen’s Life Sciences ...

MONTPELLIER, France, April 10, 2024--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 ... field of hearing loss disorders, today announces its participation in the Van Lanschot Kempen's Life ...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 ... the field of hearing loss disorders, today announces its participation in the Van Lanschot Kempen's Life Sciences ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...